Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
Accurate detection of recurrent colorectal carcinoma remains a clinical challenge. Positron emission tomography (PET) using 18F-fluorodeoxyglucose ( 18FDG) is an imaging technique that allows direct evaluation of cellular metabolism. 18F-fluorodeoxyglucose PET was compared to computed tomography (CT...
Saved in:
Published in: | The American journal of surgery Vol. 171; no. 1; pp. 21 - 26 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
1996
Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Accurate detection of recurrent colorectal carcinoma remains a clinical challenge. Positron emission tomography (PET) using
18F-fluorodeoxyglucose (
18FDG) is an imaging technique that allows direct evaluation of cellular metabolism.
18F-fluorodeoxyglucose PET was compared to computed tomography (CT) and CT portography for staging metastatic colorectal carcinoma.
Twenty-four patients previously treated for colorectal carcinoma who had suspected recurrence to the liver underwent an
18FDG PET scan of the entire body. All patients had either a CT scan of the abdomen (n = 17), a CT portogram (n = 18), or both (n = 11). The final diagnosis was obtained by tissue pathology in 19 patients and clinical follow-up in 5 patients.
A total of 60 suspicious lesions were identified. Of the 55 intrahepatic lesions, 39 were malignant and 16 were benign. Of the 5 extrahepatic lesions, 4 were malignant. The
18FDG PET imaging had a higher accuracy (93%) than CT and CT portography (both 76%) in detecting metastatic disease to the liver, and detected unsuspected extrahepatic recurrence in 4 patients. Although the sensitivity of
18FDG PET (90%) was slightly lower than that of CT portography (97%), the specificity was much higher (100% versus 9%), including postsurgical sites.
18FDG PET altered surgical plans in 6 (25%) of 24 patients.
18FDG PET is extremely useful in staging patients with suspected metastatic colorectal carcinoma to the liver. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0002-9610 1879-1883 |
DOI: | 10.1016/S0002-9610(99)80067-1 |